Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark William Ahrens-Townsend Insider Profile
4 Followers
Mark William Ahrens-Townsend, President & Chief Executive Officer at Kane Biotech, holds 1.29M shares in Kane Biotech (Ticker: TSE:KNE). Most recently, Mark William Ahrens-Townsend Bought C$20,000 shares of Kane Biotech on Mar 28, 2018 for an estimated value of 1.90K.
Mark William Ahrens-Townsend Kane Biotech (KNE)President & Chief Executive Officer
Kane Biotech (KNE)
President & Chief Executive Officer
Ranked #82,130 out of 98,042 Corporate Insiders
Profitable Transactions
4 out of 12 Profitable Transactions
Average Return
-15.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Mark William Ahrens-Townsend's holdings
Insider Roles
President & Chief Executive Officer
Roles that Mark William Ahrens-Townsend holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mark William Ahrens-Townsend
Mark William Ahrens-Townsend's Trading History
List of latest transactions for each holding click on a transaction to see Mark William Ahrens-Townsend's performance on stock
You May Also Like
Mark William Ahrens-Townsend insider profile FAQ
What is the percentage of profitable transactions made by Mark William Ahrens-Townsend?
The percentage of profitable transactions made by Mark William Ahrens-Townsend is 33%.
What is the average return per transaction made by Mark William Ahrens-Townsend?
The average return per transaction made by Mark William Ahrens-Townsend is -15.60%.
What stocks does Mark William Ahrens-Townsend hold?
Mark William Ahrens-Townsend holds: TSE:KNE stocks.
What was Mark William Ahrens-Townsend’s latest transaction?
Mark William Ahrens-Townsend latest transaction was an Informative Buy of C$1.90K.
What was Mark William Ahrens-Townsend's most profitable transaction?
Mark William Ahrens-Townsend’s most profitable transaction was an Informative Buy of TSE:KNE stock on June 11, 2015. The return on the trade was 14.30%.
What is Mark William Ahrens-Townsend's role in Kane Biotech?
Mark William Ahrens-Townsend's role in Kane Biotech is President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.